Skip to content

Advertisement

  • Case report
  • Open Access
  • Open Peer Review

An atypical presentation of an ovarian lymphoma: a case report

  • 1Email author,
  • 2 and
  • 3
Journal of Medical Case Reports201812:338

https://doi.org/10.1186/s13256-018-1884-8

  • Received: 15 March 2018
  • Accepted: 17 October 2018
  • Published:
Open Peer Review reports

Abstract

Background

Ovarian lymphoma has a varied clinical presentation and rarely presents with heavy menstrual bleeding. It may occur de novo or secondary to systemic disease and macroscopically appear as solid ovarian tumors.

Case presentation

A 32-year-old Tamil woman presented with heavy menstrual bleeding of 4 months’ duration. On examination she was anemic with no lymphadenopathy. A large immobile pelvic mass and three firm nodules were found involving her vaginal walls. Ultrasonography suggested a fibroid uterus with two large pedunculated fibroids. Following preoperative optimization an endometrial sampling and biopsy of the nodules were done. Subsequently, histology revealed proliferative phase endometrium. The vaginal nodules showed lymphoid tissue.

She presented a week later with an undulating fever and features of acute abdomen with clinical evidence of ascites. During an emergency laparotomy two large solid ovarian masses, gross ascites, pelvic lymph nodes, para-aortic lymph nodes, mesenteric lymph nodes, omental deposits, and a 24-week-size uterus were found. Bilateral oophorectomy was done. Laboratory investigations revealed raised lactate dehydrogenase with normal serum β-human chorionic gonadotropin, alpha-fetoprotein, and cancer antigen-125 levels. Histology of ovarian specimens revealed a diffuse large B cell lymphoma.

A bone marrow biopsy revealed more than 80% infiltration with lymphoid cells. Two weeks after the laparotomy a computed tomography of her chest, abdomen, and pelvis revealed a pelvic mass, gross ascites, omental deposits, hepatosplenomegaly, and enlarged lymph nodes above and below her diaphragm. Immunohistochemistry confirmed the diagnosis of B cell lymphoblastic lymphoma. She was classified as stage IV E non-Hodgkin’s lymphoma on the Ann Arbor staging system.

Conclusion

This is an atypical presentation of an ovarian lymphoma. The atypical presentations of ovarian lymphomas can lead to diagnostic dilemmas.

Keywords

  • Ovarian lymphoma
  • Non-Hodgkin’s lymphoma
  • Case report

Background

Lymphomas presenting with gynecological symptoms are rare. Involvement of the ovary by malignant lymphoma can be primary or secondary [13]. The difference between primary and secondary lymphomas is important in terms of prognosis [4]. Primary ovarian lymphomas present as solid ovarian tumors with an overall incidence of 0.5% of all non-Hodgkin’s lymphomas (NHLs) and 1.5% of all ovarian malignancies [5]. Secondary deposits can also occur following dissemination of systemic disease [6]. For therapeutic purposes ovarian lymphomas are regarded as manifestations of systemic disease and staged as per the Ann Arbor classification [7].

Case presentation

A 32-year-old Tamil woman presented with heavy menstrual bleeding of 4 months’ duration. She had no previous gynecological issues and had delivered two children vaginally. Her past medical history and family history were unremarkable. There were no psychosocial stresses. On examination she was pale, had no palpable lymph nodes, no hepatosplenomegaly, a large pelvic mass, and three firm vaginal nodules. Her hemoglobin was 5.2 g/dl and she had a white blood cell count of 9100/mm3 with 50% lymphocytes and platelets of 487,000/mm3. Blood picture showed evidence of microcytic anemia. A pelvic ultrasound suggested a fibroid uterus with two large pedunculated fibroids. Following preoperative optimization, dilatation and curettage and biopsy of the vaginal nodules were done. Histology revealed proliferative phase endometrium. The vaginal nodules showed lymphoid tissue.

A week later, she developed fever, features of an acute abdomen, and ascites. Her white blood cell count had risen to 36,000/mm3 with predominant lymphocytes. An emergency laparotomy was done which revealed two solid ovarian masses (Fig. 1), gross ascites, omental deposits, enlarged mesenteric lymph nodes, and a bulky uterus with thickened infundibulopelvic pedicles. A bilateral oophorectomy was done for histological diagnosis and to relieve bowel compression. A hysterectomy was not done as there was pelvic side wall involvement. Her lactate dehydrogenase (LDH) was 2250 IU/L with normal serum β-human chorionic gonadotropin (β-hCG), alpha-fetoprotein (AFP), and cancer antigen-125 (CA-125) levels. Histology revealed a diffuse large B cell lymphoma. As her general condition was deteriorating, she was started on the cyclophosphamide, adriamycin, vincristine, and prednisolone (CHOP) chemotherapy regimen while awaiting staging investigations. She had a dramatic clinical improvement with the first cycle of chemotherapy.
Fig. 1
Fig. 1

Cut surface of right ovarian tumor

A bone marrow biopsy revealed 80% infiltration with lymphoid cells. Imaging showed enlarged lymph nodes above and below her diaphragm, ascites, and hepatosplenomegaly. Immunohistochemistry revealed focal CD20 staining and nuclear positivity for terminal deoxynucleotidyl transferase (TdT) and scattered CD3 positivity which suggested a B cell lymphoblastic lymphoma. Considering the blood count with bone marrow findings, a diagnosis of lymphoblastic lymphoma/leukemia was made according to World Health Organization (WHO) classification [8]. Cerebrospinal fluid (CSF) cytology was normal. Cytogenetics was not done due to financial constraints.

She was later commenced on UKALL XII Trial protocol containing prednisolone, vincristine, daunorubicin, asparaginase, and intrathecally administered methotrexate and was in remission at the end of phase 1 induction chemotherapy. However she developed hepatotoxicity which precluded continuation of chemotherapy and eventually she died. A timeline to show disease progression is shown in Fig. 2.
Fig. 2
Fig. 2

Timeline showing disease progression in patient. CHOP cyclophosphamide, adriamycin, vincristine, and prednisolone chemotherapy regimen, CT computed tomography, D&C dilatation and curettage, EUA evaluation under anesthesia, UKALL XII prednisolone, vincristine, daunorubicin, asparaginase and intrathecally administered methotrexate prednisolone

Discussion

The initial blood picture in this patient suggested a microcytic anemia likely to be due to heavy menstrual bleeding. The subsequent endometrial sampling did not contribute to the eventual diagnosis. Even the presentation of an acute abdomen following endometrial sampling suggested a surgical complication rather than a hematological malignancy. Furthermore, the operative findings of ascites and solid ovarian masses can also be interpreted as a disseminated ovarian malignancy. Only the mesenteric nodes and the abnormal appearance of the uterine ligaments suggested a more sinister cause.

The common differential diagnosis of solid ovarian tumors includes Brenner tumors, teratomas, dysgerminomas, ovarian fibromas, ovarian thecomas, granulosa cell tumors, and Krukenberg tumors [9]. A definitive pathological diagnosis was made after immunostaining. In our case CD20, TdT, and scattered CD3 positivity suggested a B cell lymphoblastic lymphoma. Secondary involvement of the genital tract by NHL is a rare presentation ante-mortem. In these patients, the ovaries are predominantly involved by B cell phenotypes, of which diffuse large B cell lymphoma is the commonest subtype.

It is difficult to determine whether the lymphoma is primary or secondary once it is disseminated. Although a generalized disease with secondary ovarian deposits is commoner than a primary ovarian lymphoma, factors which suggested the latter were: an initially normal white cell count and a blood picture showing only microcytic anemia and the operative findings of the largest deposits being ovarian deposits. Whether it was a primary or secondary ovarian lymphoma was important only in terms of prognosis as all lymphomas of the ovary should be regarded as local manifestations of systemic disease for therapeutic purposes [4, 7]. Furthermore, the prognosis of ovarian lymphomas is often poor because of delayed diagnosis. The best treatment option seems to be chemotherapy and gynecologists should be aware of this rare presentation to avoid unnecessary radical surgery [10].

Unfortunately, despite an initial rapid recovery following chemotherapy, the progressive hepatic dysfunction ruled out the possibility of continuing chemotherapy which led to disease progression and the eventual death of our patient.

Conclusions

Ovarian lymphomas will present with atypical signs and symptoms which raise diagnostic and therapeutic dilemmas. In these rare instances, they can mimic ovarian malignancy and can lead to inevitable surgical interventions.

Declarations

Acknowledgements

We would like to express our sincere gratitude to: the relatives of the patient; Dr C Rajasooriyar, Oncologist, and staff of the Oncology ward, ‘Trail’ Cancer Hospital, Tellippalai; and staff of the Gynaecology ward, District General Hospital, Mannar.

Funding

The authors declare that they have no funding source.

Availability of data and materials

Not applicable.

Authors’ contributions

CE and RP were the gynecologist and pathologist involved in the management, respectively. CE wrote the manuscript. PW provided expert advice. All authors read and approved the final version.

Ethics approval and consent to participate

Not applicable.

Consent for publication

Written informed consent was obtained from the patient’s next-of-kin for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Obstetrics and Gynaecology Unit, District General Hospital, Mannar, Sri Lanka
(2)
Department of Pathology, District General Hospital, Kalutara, Sri Lanka
(3)
Department of Obstetrics & Gynaecology, Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka

References

  1. Kumar N, Kumar R, Bera A, Srinivasan R, Sharma S. Primary Ovarian Lymphoma: A Case Report and Review of Literature. J Obstet Gynecol India. 2014;64(1):65–7. https://doi.org/10.1007/s13224-012-0200-6.View ArticleGoogle Scholar
  2. Bhartiya R, Kumari N, Mallik M, Narayan Singh R. Primary Non-Hodgkin’s Lymphoma of the Ovary – A Case Report. J Clin Diagn Res. 2016;5:10–1.Google Scholar
  3. Taskin M, Gokgozoglu L, Kandemir B. Primary Ovarian Large B-Cell Lymphoma. Case Rep Obstet Gynecol. 2013:493836. 3. https://doi.org/10.1155/2013/493836 View ArticleGoogle Scholar
  4. Weingertner A, Hamid D, Roedlich M, Baldauf J. Non-Hodgkin malignant lymphoma revealed by an ovarian tumor: case report and review of the literature. Gynecol Oncol. 2004;95(3):750–4.View ArticleGoogle Scholar
  5. Dimopoulos MA, Daliani D, Pugh W, Gershenson D, Cabanillas F, Sarris AH. Primary ovarian non-Hodgkin’s lymphoma: Outcome after treatment with combination chemotherapy. Gynecol Oncol. 1997;64:446–50.View ArticleGoogle Scholar
  6. Elharroudi T, Ismaili N, Errihani H, Jalil A. Primary lymphoma of the ovary. J Can Res Ther. 2008;4:195–6.View ArticleGoogle Scholar
  7. Fox H, Langley FA, Govan AD, Hill AS, Bennett MH. Malignant lymphoma presenting as an ovarian tumour: a clinicopathological analysis of 34 cases. Br J Obstet Gynaecol. 1988;95(4):386–90.View ArticleGoogle Scholar
  8. Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114(5):937–51.View ArticleGoogle Scholar
  9. Tyagi S, Maheswari V, Tyagi N, Saxena K, Sharma R, Hameed F. Solid tumours of the ovary. J Indian Med Assoc. 1993;91(9):227–30.PubMedGoogle Scholar
  10. Senol T, Doger E, Kahramanoglu I, Geduk A, Kole E, Yucesoy I, et al. Five Cases of Non-Hodgkin B-Cell Lymphoma of the Ovary. Case Rep Obstet Gynecol. 2014:392758, 5. https://doi.org/10.1155/2014/392758.View ArticleGoogle Scholar

Copyright

© The Author(s). 2018

Advertisement